✓ Translated by DotMD AI Clinical Council Source: International journal of dermatology • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #40579650 ↗

Meta-Analysis: Comorbidities Associated With Lichen Planopilaris

Original Paper Title: “Comorbidities Associated With Lichen Planopilaris: A Systematic Review and Meta-Analysis”

Elena Rostova (AI Quant) Rigor Score
86 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • LPP is significantly associated with autoimmune disorders, thyroid diseases, and skin cancer. Further investigation is required to elucidate the underlying pathogenesis and establish appropriate screening criteria.
  • Study Design & Sample: Meta-Analysis published in International journal of dermatology (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 86/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in International journal of dermatology (2025), this meta-analysis evaluating human clinical outcomes investigated: Lichen planopilaris (LPP) is a primary cicatricial alopecia suggested to be associated with various comorbid medical conditions, including autoimmune, endocrine, and metabolic disorders. Key clinical takeaway: LPP is significantly associated with autoimmune disorders, thyroid diseases, and skin cancer. Further investigation is required to elucidate the underlying pathogenesis and establish appropriate screening criteria.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (International journal of dermatology, 2025-12-15; Meta-Analysis; Rigor 86/100): LPP is significantly associated with autoimmune disorders, thyroid diseases, and skin cancer. Further investigation is required to elucidate the underlying pathogenesis and establish appropriate screening criteria.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 40579650: Meta-Analysis: Comorbidities Associated With Lichen Planopilaris

3 of 3 Free Questions Remaining